Back to search

Article

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

2020-12-18

Abstract excerpt

<h4>Introductory paragraph</h4> The clinical success of targeted cancer therapy is limited by drug resistance that renders cancers lethal in patients 1-4 . Human tumours can evolve therapy resistance by acquiring de novo genetic alterations and increased heterogeneity via mechanisms that remain incompletely understood 1 . Here, through parallel analysis of human clinical samples, tumour xenograft and cell line...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
44b756bd-c7e8-5740-8ffb-5b84e4f9e4d5
DOI
10.1101/2020.12.18.423280
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistanceDOI 10.1101/2020.12.18.423280
Select a neighboring publication to make it the new centre.